Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost.

Abstract

AIM:

We aimed to summarize the pooled effect of early discharge compared with ordinary discharge after percutaneous coronary intervention (PCI) on the composite endpoint of re-infarction, revascularization, stroke, death, and incidence of rehospitalization. We also aimed to compare costs for the two strategies.

METHODS:

The study was a systematic review and a meta-analysis of 12 randomized controlled trials including 2962 patients, followed by trial sequential analysis. An estimation of cost was considered. Follow-up time was 30 days.

RESULTS:

For early discharge, pooled effect for the composite endpoint was relative risk of efficacy (RRe)=0.65, 95% confidence interval (CI) (0.52-0.81). Rehospitalization had a pooled effect of RRe=1.10, 95% CI (0.88-1.38). Early discharge had an increasing risk of rehospitalization with increasing frequency of hypertension for all populations, except those with stable angina, where a decreasing risk was noted. Advancing age gave increased risk of revascularization. Early discharge had a cost reduction of 655 Euros per patient compared with ordinary discharge.

CONCLUSION:

The pooled effect supports the safe use of early discharge after PCI in the treatment of a heterogeneous population of patients with coronary artery disease. There was an increased risk of rehospitalization for all subpopulations, except patients with stable angina. Clinical trials with homogeneous populations of acute coronary syndrome are needed to be conclusive on this issue.

• Authors: Michael Abdelnoor, Jack Gunnar Andersen, Harald Arnesen, Odd Johansen
• Journal: Vascular health and risk management (Vasc Health Risk Manag) Vol. 13 Pg. 101-109 ( 2017) ISSN: 1178-2048 [Electronic] New Zealand
• PMID: 28356750 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)

Topics

• Aged
• Cost-Benefit Analysis
• Female
• Hospital Costs
• Humans
• Length of Stay (economics)
• Male
• Middle Aged
• Myocardial Ischemia (diagnosis, economics, mortality, therapy)
• Patient Discharge (economics)
• Patient Readmission (economics)
• Percutaneous Coronary Intervention (adverse effects, economics, mortality)
• Process Assessment, Health Care (economics)
• Randomized Controlled Trials as Topic
• Retreatment (economics)
• Risk Assessment
• Risk Factors
• Time Factors
• Treatment Outcome